WHO Urges Equal Treatment and Ban on Flavored E-cigarettes

Regulations by 2FIRSTS.ai
Dec.14.2023
WHO Urges Equal Treatment and Ban on Flavored E-cigarettes
World Health Organization (WHO) urges governments to treat e-cigarettes like traditional tobacco, threatening tobacco companies' investment in tobacco alternatives.

According to a report by Reuters in London, the World Health Organization (WHO) released a document on December 14 urging governments worldwide to treat e-cigarettes on par with traditional tobacco and ban all flavors, which could potentially jeopardize tobacco companies' investments in tobacco alternatives.

 

Some researchers, advocates, and governments view e-cigarettes as a crucial tool in reducing deaths and diseases caused by tobacco. However, United Nations agencies state that "urgent action" is needed to control them.

 

The World Health Organization cites some studies stating that there is insufficient evidence to confirm e-cigarettes' effectiveness in helping smokers quit and that they are harmful to one's health, potentially leading to nicotine addiction, especially among non-smokers, particularly children and adolescents.

 

In global regions influenced by the World Health Organization, the number of 13-15 year old teenagers using e-cigarettes has surpassed that of adults. The WHO's press release cites strong marketing tactics as a driving force behind the popularity of e-cigarettes.

 

According to the World Health Organization, "children and adolescents are lured and enslaved by e-cigarette at an early age, which could lead to nicotine addiction.

 

The Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus, has called on countries to implement stringent measures.

 

The World Health Organization (WHO) has called for changes that include banning all additives, such as menthol, in addition to implementing tobacco control measures on e-cigarettes, such as high taxes and restrictions on their use in public places. However, it is important to note that the WHO does not have authoritative power over national regulations and can only provide guidelines. These recommendations are usually voluntarily adopted and implemented.

 

The World Health Organization and several other anti-tobacco organizations are advocating for stricter regulations on new nicotine products, aiming to undermine the future strategies of tobacco giants like Philip Morris International (PMI) and British American Tobacco.

 

Major tobacco companies are seeking to establish new sources of revenue by embracing tobacco alternatives in order to counter the declining smoking rates and stringent regulations faced by certain markets.

 

The tobacco industry claims that e-cigarettes pose significantly fewer health risks than traditional tobacco and can help reduce the harms associated with smoking. They argue that certain flavors and lower prices are crucial in encouraging smokers to switch to e-cigarettes, a viewpoint that is also shared by some tobacco control advocates.

 

The World Health Organization has reported that e-cigarettes produce certain substances, some of which are known to be carcinogenic and pose risks to heart and lung health. The report cites studies indicating that they also harm the brain development of young individuals.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
Philip Morris International (PMI) is expanding its investment in its Golden, Colorado campus, bringing total investment to approximately $1.2 billion to support its smoke-free products business. The investment will strengthen PMI’s research, production and innovation capabilities in smoke-free products. As one of the world’s largest tobacco companies, PMI has continued advancing its “Smoke-Free Future” strategy through heated tobacco, oral nicotine and other reduced-risk product categories.
PMI
Jul.28
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey, daily smoking among Australians aged 18 and over fell to a record low of 5.8% in 2025. Health Minister Mark Butler said Australia now has around 500,000 fewer daily smokers than three years ago and credited the government’s vaping reforms as part of broader progress. Among people aged 14 and over, daily smoking declined from 8.3% in 2022-23 to 5.6% in 2025. Daily vaping rates stabilised at 3.6%, while the government also moved to further restrict access to nicotine pouches through unapproved therapeutic import pathways.
Jul.21
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
U.S. Customs Plan to Require Foreign Export Declarations Could Deal ‘Devastating’ Blow to China’s Vape Exports, Logistics gl Expert Says
A U.S. Customs and Border Protection proposal to collect foreign export declarations and other overseas customs documents could expose discrepancies in the value, classification and description of China-made vape shipments entering the United States. A veteran Chinese logistics professional told 2Firsts that the measure, if implemented, could undermine the all-inclusive shipping model used by some unauthorized vape exporters and push parts of the trade toward costlier underground channels. The risk extends beyond higher duties: accurately declared products may also be more readily identified as unauthorized e-cigarettes subject to FDA enforcement.
Special Report
Sep.07
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19